These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26439664)

  • 21. [The strategies of endosomal escape for intracellular gene delivery].
    Wang WX; Dai K; Hong L; Cai T; Tang L
    Yao Xue Xue Bao; 2014 Aug; 49(8):1111-6. PubMed ID: 25322551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance.
    Oliveira C; Silveira I; Veiga F; Ribeiro AJ
    Expert Opin Drug Deliv; 2015 Jan; 12(1):27-39. PubMed ID: 25141765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PepFect14 peptide vector for efficient gene delivery in cell cultures.
    Veiman KL; Mäger I; Ezzat K; Margus H; Lehto T; Langel K; Kurrikoff K; Arukuusk P; Suhorutšenko J; Padari K; Pooga M; Lehto T; Langel Ü
    Mol Pharm; 2013 Jan; 10(1):199-210. PubMed ID: 23186360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids.
    Khalil IA; Younis MA; Kimura S; Harashima H
    Biol Pharm Bull; 2020; 43(4):584-595. PubMed ID: 32238701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro design and characterization of the nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent.
    Higgins LJ; Hwang GL; Rosenberg J; Katzenberg RH; Kothary N; Sze DY; Hofmann LV
    J Vasc Interv Radiol; 2011 Oct; 22(10):1457-1463.e2. PubMed ID: 21856173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonviral gene delivery: what we know and what is next.
    Gao X; Kim KS; Liu D
    AAPS J; 2007 Mar; 9(1):E92-104. PubMed ID: 17408239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low RNA translation activit limits the efficacy of hydrodynamic gene transfer to pig liver in vivo.
    Sendra L; Carreño O; Miguel A; Montalvá E; Herrero MJ; Orbis F; Noguera I; Barettino D; López-Andújar R; Aliño SF
    J Gene Med; 2014; 16(7-8):179-92. PubMed ID: 25092576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonviral gene delivery: principle, limitations, and recent progress.
    Al-Dosari MS; Gao X
    AAPS J; 2009 Dec; 11(4):671-81. PubMed ID: 19834816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting.
    Jiang HL; Kwon JT; Kim YK; Kim EM; Arote R; Jeong HJ; Nah JW; Choi YJ; Akaike T; Cho MH; Cho CS
    Gene Ther; 2007 Oct; 14(19):1389-98. PubMed ID: 17637795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-directed gene transfer vectors.
    Ferry N; Heard JM
    Hum Gene Ther; 1998 Sep; 9(14):1975-81. PubMed ID: 9759925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity.
    Wan Y; Moyle PM; Christie MP; Toth I
    Nanomedicine (Lond); 2016 Apr; 11(8):907-19. PubMed ID: 26979574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo.
    Chemin I; Moradpour D; Wieland S; Offensperger WB; Walter E; Behr JP; Blum HE
    J Viral Hepat; 1998 Nov; 5(6):369-75. PubMed ID: 9857346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell.
    Mustapa MF; Grosse SM; Kudsiova L; Elbs M; Raiber EA; Wong JB; Brain AP; Armer HE; Warley A; Keppler M; Ng T; Lawrence MJ; Hart SL; Hailes HC; Tabor AB
    Bioconjug Chem; 2009 Mar; 20(3):518-32. PubMed ID: 19228071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-viral gene delivery: from the needle to the nucleus.
    Rettig GR; Rice KG
    Expert Opin Biol Ther; 2007 Jun; 7(6):799-808. PubMed ID: 17555366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.
    Donkuru M; Badea I; Wettig S; Verrall R; Elsabahy M; Foldvari M
    Nanomedicine (Lond); 2010 Sep; 5(7):1103-27. PubMed ID: 20874024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy progress and prospects: nonviral vectors.
    Niidome T; Huang L
    Gene Ther; 2002 Dec; 9(24):1647-52. PubMed ID: 12457277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging vectors and targeting methods for nonviral gene therapy.
    Lavigne MD; Górecki DC
    Expert Opin Emerg Drugs; 2006 Sep; 11(3):541-57. PubMed ID: 16939390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Status of Nonviral Vectors for Gene Therapy in China.
    Liu L; Yang J; Men K; He Z; Luo M; Qian Z; Wei X; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):110-120. PubMed ID: 29320893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical vectors for gene delivery: uptake and intracellular trafficking.
    Pichon C; Billiet L; Midoux P
    Curr Opin Biotechnol; 2010 Oct; 21(5):640-5. PubMed ID: 20674331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current progress in researches on the gene delivery systems based on nanoparticles technology].
    Qi X; Xu H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1376-9. PubMed ID: 20095507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.